Lifevantage Corp (LFVN) stock
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.78+0.01 (+0.21%)
Close on Nov 17, 2026Market cap $59.88MP/E 11.9Yield 3.87%
Lifevantage price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Lifevantage's price to book ratio was 1.8× on Nov 11, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 1.3× to 9.5×, with a median of 2.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.8× | −0.6 |
| 2025 | Dec 31, 2025 | 2.4× | −5.5 |
| 2024 | Dec 31, 2024 | 7.9× | +5.3 |
| 2023 | Dec 29, 2023 | 2.6× | +1.1 |
| 2022 | Dec 30, 2022 | 1.5× | −0.8 |
| 2021 | Dec 31, 2021 | 2.2× | −1.6 |
| 2020 | Dec 31, 2020 | 3.9× | −3.5 |
| 2019 | Dec 31, 2019 | 7.4× | −0.5 |
| 2018 | Dec 31, 2018 | 7.9× | +3.6 |
| 2017 | Dec 29, 2017 | 4.3× | −3.8 |
| 2016 | Dec 30, 2016 | 8.1× | −20.9 |
| 2015 | Dec 31, 2015 | 29.1× | +10.9 |
| 2014 | Dec 31, 2014 | 18.2× | +12.7 |
| 2013 | Dec 31, 2013 | 5.5× | −1.7 |
| 2012 | Dec 31, 2012 | 7.2× | – |
See a number that looks wrong?